Cite
HARVARD Citation
Ruzehaji, N. et al. (2016). Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis. Annals of the rheumatic diseases. 75 (12), pp. 2175-2183. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruzehaji, N. et al. (2016). Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis. Annals of the rheumatic diseases. 75 (12), pp. 2175-2183. [Online].